Literature DB >> 8396017

An intact and functional soluble form of the insulin receptor is secreted by cultured cells.

V Papa1, P Russo, B Gliozzo, I D Goldfine, R Vigneri, V Pezzino.   

Abstract

We have recently reported that the insulin receptor (IR), a tetrameric transmembrane protein located on the surface of target cells, is present as a soluble form in human plasma. In the present study we investigated whether human cells in culture release an intact and functional form of the IR. We found that IRs are secreted into the incubation medium by four cell lines (IM-9 human lymphoblasts, MCF-7 human breast cancer cells, HepG2 human hepatoma cells, and 3T3 mouse fibroblasts transfected with human IRs). IR secretion was further characterized in IM-9 cells. IR release was time, temperature, and energy dependent, and enhanced by incubation with insulin. The dilution slope of secreted IRs in a specific IR RIA was parallel to that produced by highly purified human placenta IRs. Ligand binding studies revealed that secreted receptors bound insulin with high affinity, and the Scatchard analysis revealed two orders of binding sites (the high affinity site had a dissociation constant of 0.32 +/- 0.08 nM). Analysis of secreted receptors by sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated a molecular size of 135 kilodaltons for the alpha-subunit and 95 kilodaltons for the beta-subunit. Other experiments indicated that the beta-subunit tyrosine kinase activity of the secreted receptor was stimulated by insulin. These studies indicate, therefore, that a soluble, intact, and functional IR is secreted by cultured cells, and that this soluble protein could be involved in certain insulin-mediated functions, such as receptor down-regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396017     DOI: 10.1210/endo.133.3.8396017

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells.

Authors:  S Efthimiopoulos; D Vassilacopoulou; J A Ripellino; N Tezapsidis; N K Robakis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

2.  Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer.

Authors:  P Massoner; M Ladurner-Rennau; I E Eder; H Klocker
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

3.  Detection, purification and identification of an endogenous inhibitor of L-Dopa decarboxylase activity from human placenta.

Authors:  Alice-Georgia Vassiliou; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Neurochem Res       Date:  2008-11-13       Impact factor: 3.996

4.  Characterization and identification of PARM-1 as a new potential oncogene.

Authors:  Cyndia Charfi; Louis-Charles Levros; Elsy Edouard; Eric Rassart
Journal:  Mol Cancer       Date:  2013-07-31       Impact factor: 27.401

5.  Release of Soluble Insulin Receptor From Neurons by Cerebrospinal Fluid From Patients With Neurocognitive Dysfunction and HIV Infection.

Authors:  Yamil Gerena; Raissa Menéndez-Delmestre; Andrea Delgado-Nieves; Joyce Vélez; Jarold Méndez-Álvarez; Javier E Sierra-Pagan; Richard L Skolasky; Lisa Henderson; Avindra Nath; Valerie Wojna
Journal:  Front Neurol       Date:  2019-03-26       Impact factor: 4.003

6.  Insulin receptor cleavage induced by estrogen impairs insulin signaling.

Authors:  Tomoyuki Yuasa; Yasunori Takata; Nanako Aki; Kotaro Kunimi; Miki Satoh; Mari Nii; Yoshihiko Izumi; Toshiki Otoda; Seiichi Hashida; Haruhiko Osawa; Ken-Ichi Aihara
Journal:  BMJ Open Diabetes Res Care       Date:  2021-12

7.  Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells.

Authors:  Rive Sarfstein; Antonino Belfiore; Haim Werner
Journal:  Cancers (Basel)       Date:  2010-03-25       Impact factor: 6.639

8.  Hyperinsulinemia is Associated with Increased Soluble Insulin Receptors Release from Hepatocytes.

Authors:  Marcia Hiriart; Carmen Sanchez-Soto; Carlos Manlio Diaz-Garcia; Diana T Castanares; Morena Avitia; Myrian Velasco; Jaime Mas-Oliva; Marina Macias-Silva; Clicerio González-Villalpando; Blanca Delgado-Coello; Marcela Sosa-Garrocho; Román Vidaltamayo; Deyanira Fuentes-Silva
Journal:  Front Endocrinol (Lausanne)       Date:  2014-06-19       Impact factor: 5.555

9.  The beta secretase BACE1 regulates the expression of insulin receptor in the liver.

Authors:  Paul J Meakin; Anna Mezzapesa; Eva Benabou; Mary E Haas; Bernadette Bonardo; Michel Grino; Jean-Michel Brunel; Christèle Desbois-Mouthon; Sudha B Biddinger; Roland Govers; Michael L J Ashford; Franck Peiretti
Journal:  Nat Commun       Date:  2018-04-03       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.